This literature review has outlined the great potential for ASOs to be used as a treatment for DS through downregulating DYRK1A. We aimed to distil current research perspectives on DS, DYRK1A, and ASOs to justify the potential of using ASOs to address the cognitive deficits associated with DS. Here, DYRK1A is linked to Dravet syndrome.